Stock LSL LSL PHARMA GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages LSL Pharma Group Inc.

Equities

LSL

CA50190N1042

End-of-day quote Toronto S.E.
Other stock markets
 23:00:00 29/05/2024 BST 		5-day change 1st Jan Change
0.51 CAD -.--% Intraday chart for LSL Pharma Group Inc. +2.00% +5.15%
05-06 LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings MT
05-06 LSL Pharma Group Inc. entered into a binding Letter of Intent to acquire Target Co for CAD 2.5 million. CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
LSL Pharma Group Announces Listing of Convertible Redeemable Debentures on the TSXV
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor
LSL Pharma Group Inc. entered into a binding Letter of Intent to acquire Target Co for CAD 2.5 million.
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
LSL Pharma Group Brief: Said Earlier Wednesday It Secured $3.8 Million As the Second And Final Tranche Of Its Private Placement Of Units
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
LSL Pharma Group Inc. announced that it has received CAD 6.479426 million in funding from Alfera Pharmaceuticals, LLC
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
LSL Pharma Group Inc. Appoints Diane Beaudry and Mario Paradis to Its Board of Directors
LSL Pharma Group Brief: Has Upsized Its Private Placement From $3.5 Million To $7.5 Million
LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million
LSL Pharma Group Announces its Participation in the "2024 Bloom Burton & Co. Healthcare Investor Conference "
LSL Pharma Group Announces its Participation in the "2024 Bloom Burton & Co. Healthcare Investor Conference "
LSL Pharma Loses 5% As Raises $6.44 Million In First Closing Of Private Placements
LSL Pharma Raises $6.44 Million In First Closing Of Private Placements
LSL Pharma Group Secures $6.44 Million as the First Closing of Concurrent Non-Brokered Private Placements
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LSL Stock
  4. News LSL Pharma Group Inc.
  5. Other languages